Daily Morning Note – 31 Aug 2020


Wall Street flexed its muscles on Friday, with the Dow erasing its losses for the year and the S&P and Nasdaq again hitting records as investors shrugged off the ongoing coronavirus crisis, while markets elsewhere saw more moderate trading.

Much of the positive sentiment can be attributed to the Federal Reserve, which made clear that US interest rates will stay ultra-low as long as needed in a major policy shift announced Thursday.

That further buoyed stocks that had already climbed following their March Covid-19 downturn, after the Fed offered trillions of dollars in liquidity to keep markets functioning normally, with tech stocks doing particularly well as consumers spent more time at home.


Micro-Mechanics on Friday reported a 45.5 per cent rise in its net profit to about S$3.9 million for its fourth fiscal quarter ended June 30, 2020, from S$2.7 million in the year-ago period. Strong revenue growth gave a boost to its bottom line, said the mainboard-listed company, which manufactures high-precision tools and parts used in process-critical applications for the semiconductor industry.

Natural rubber supplier Halcyon Agri Corp has proposed the issuance of guaranteed perpetual securities as its latest fundraising option, rather than the earlier proposed rights issue. In a regulatory filing, the mainboard-listed firm said this move is a “more optimal and equitable” funding option amid current market conditions.

Keppel Corporation, which owns a 40 per cent stake in upstream oil and gas company KrisEnergy, on Sunday said it is prepared to support the final restructuring proposal of the debt-hit firm. In a bourse filing, Keppel Corp said it has evaluated KrisEnergy’s debt workout plan, which it believes is a “deliverable plan”.

Mainboard-listed Wing Tai Holdings reported a net loss of S$16.8 million for the second half ended June 30, down from net profit of S$28.4 million in the year-ago period, in its results release on Friday after market close.

Neo Group is looking to make its foray into property development, investment and management. This will mean expanding its existing core business of providing end-to-end food and catering solutions, the Catalist-listed firm announced on Friday.

Property developer Oxley Holdings recorded a net loss of S$296.3 million for the second half of the financial year ended June 30, on the back of other losses incurred due to the Covid-10 pandemic, in its results release on Friday after the market close.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


Pfizer Inc

Analyst: Chua Wei Ren

Recommended Action: Technical BUY

Pfizer Inc (US: PFE) bullish sentiment remained unchanged as reported on 18th August. Despite the selling on last week, the dojis represent a series of weakening supply and demand. Based on the technicals, we are maintaining our bullish calls.

Slack Technologies

Analyst: Chua Wei Ren

Recommendation: Technical BUY

Slack Technologies (US: WORK) bullish sentiment is still intact despite the stock had a downside reversal in late May 2020. Based on the technical, the stock will continue its bullish rally after a series of correction From June to August.

Kimberly-Clark Corp

Analyst: Chua Wei Ren

Recommendation: Technical BUY

Kimberly-Clark (US: KMB) after its extended wave E of the expanded triangle in March 2020, the stock has been growing despite a long period of correction in April to June period. Based on the technicals, the stock will be resuming its bullish upside once again.

Snap Inc.

Analyst: Chua Wei Ren

Recommendation: Technical BUY

Snap Inc (US: SNAP) since its completion of the complex expanded flat in March 2020, Snap has soared 240% in growth over a span of 4 Months. Despite a correction in July after the appearance of the Head and Shoulder pattern. However, based on the technical and wave analysis, we believe that Snap Inc. will resume its upside momentum again.

Top Glove Corporation Bhd

Analyst: Chua Wei Ren

Recommendation: Technical BUY

Top Glove Corp Bhd (SGX: BVA) has been the darling of the market since COVID-19 hits the world by storm. The exponential growth is set to continue but based on the technicals, the recent momentum indicate a lack of bullish strength at the sky high prices and as such, a slight correction is unavoidable.

>> Read more technical reports


Clearbridge Health Limit – Revenue tripled in 1H20

Recommendation: BUY (Maintained), Last Done: S$0.171

Target Price: S$0.26, Analyst: Phillip Research Team

– 1H20 revenue and EBITDA were within our expectation. 1H20 more than tripled to S$21.4mn and EBITDAR was a positive S$3.6mn. Operating cash-flow was $4.5mn in 1H20, a turnaround from the negative S$3.6mn in 1H19.

– Growth in 1H20 was driven by the acquisition of nine Singapore dental clinics in August 2019 and distribution of Biolidics COVID-19 Antibody Test Kits.

– Maintain BUY with an unchanged target price of S$0.26. We expect a stronger recovery in 2H20 for CBH. Almost all business segments suffered lower patient load in 1H20 due to the lockdown. Only renal care operations in Indonesia (i.e. TMJ) fared better as the daily dialysis treatment is essential for patients. The ability of CBH to widely and rapidly distribute the new test kit across their medical network in SE Asia was a positive surprise and represents a new growth opportunity for future products.

Phillip Securities Research has received monetary compensation for the production of the report from the entity mentioned in the report. The report was previously under the ‘SGX StockFacts Research Programme’ (administered by SGX).

SG Bonds Weekly – Week 35

Credit Analyst: Timothy Ang

– Federal Reserve Chair Jerome Powell unveiled a change in its monetary policy stance to achieve “average” inflation target, effectively signalling a shift towards allowing inflation to run higher and longer periods of low interest rates. This fuelled equity markets further on its historic rally while the US Treasury yield curve steepened on higher inflation expectations.

>> Read more research reports

HK Reports – Read up on our Hong Kong reports here


Webinar Of The Week

Market Outlook: Market Outlook: (PSR) UOB, DBS, OCBC, Manulife US, Prime US, Koufu, SG Bonds, CDL, APTT, StarHub and more

Date: 17 August 2020

For more on Market Outlook

Phillip Research in 3 minutes: #25 – Prime US REIT; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com